当前位置:首页 >财报库 > 报告详情

嘉德诺Cardinal Health(CAH) 2025财年第三季度财报「NYSE」(英文版)(52页).pdf

上传人: Kell****reet 编号:653874 2025-05-20 52页 690.11KB

下载:

1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549Form 10-QQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the quarterly period ended March 31,2025orTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE

2、 ACT OF 1934For the transition period from.to.Commission File Number:1-11373Cardinal Health,Inc.(Exact name of registrant as specified in its charter)Ohio31-0958666(State or other jurisdiction ofincorporation or organization)(IRS EmployerIdentification No.)7000 Cardinal Place,Dublin,Ohio43017(Addres

3、s of principal executive offices)(Zip Code)(614)757-5000(Registrants telephone number,including area code)Securities registered pursuant to Section 12(b)of the Act:Title of each classTrading Symbol(s)Name of each exchange on which registeredCommon shares(without par value)CAHNew York Stock ExchangeI

4、ndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)has been subject tosuch filing

5、requirements for the past 90 days.Yes No oIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule405 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or for such shorter period that the r

6、egistrant was required tosubmit such files).Yes No oIndicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,a smaller reportingcompany,or an emerging growth company.See the definitions of“large accelerated filer,”“accelerated filer,”“sm

word格式文档无特别注明外均可编辑修改,预览文件经过压缩,下载原文更清晰!
三个皮匠报告文库所有资源均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
本文是Cardinal Health, Inc.(以下简称“Cardinal Health”)2025财年第三季度10-Q报告的“管理层讨论与分析”部分。主要内容包括: 1. 收入:2025财年第三季度收入为549亿美元,与2024财年同期基本持平;2025财年前三季度收入为1624亿美元,较2024财年同期下降3%。 2. 经营收益:2025财年第三季度GAAP经营收益为7.3亿美元,同比增长98%;非GAAP经营收益为8.1亿美元,同比增长21%。2025财年前三季度GAAP经营收益为18.5亿美元,同比增长145%;非GAAP经营收益为20.7亿美元,同比增长14%。 3. 每股收益:2025财年第三季度GAAP每股收益为2.10美元,同比增长96%;非GAAP每股收益为2.35美元,同比增长13%。2025财年前三季度GAAP每股收益为5.44美元,同比增长100%;非GAAP每股收益为6.16美元,同比增长8%。 4. 现金及现金等价物:截至2025年3月31日,现金及现金等价物为33亿美元,较2024年6月30日的51亿美元有所下降。 5. 重大发展及趋势:报告期内,Cardinal Health完成了对GIA和ADSG的收购,并预计这些收购将对公司相应部门的收入和利润产生积极影响。同时,公司还面临关税带来的潜在成本增加和供应中断风险。此外,OptumRx合同的到期也对公司的经营业绩产生了不利影响。
2025财年第一季度,卡迪纳尔健康公司收入为何保持平稳? 2025财年第一季度,卡迪纳尔健康公司非GAAP经营收益为何增长21%? 2025财年第一季度,卡迪纳尔健康公司每股摊薄收益为何大幅增长?
客服
商务合作
小程序
服务号
折叠